Skip to main content
. 2024 Sep 13;54:101508. doi: 10.1016/j.ijcha.2024.101508

Table 1.

Clinical characteristics

n = 557 Median (IQR) or Number (%)
Age, years old 60 (52-70)
Gender; Male (%) 474 (85.1%)
BMI, kg/m2 24.4 (22.1-27.1)
Diabetes mellitus (%) 154 (27.6%)
Hypertension (%) 373 (67.0%)
Dyslipidemia (%) 388 (69.7%)
Smoking (%) 377 (67.7%)
Laboratory findings
BNP, pg/mL 26.5 (11.2-74.8)
Albumin, g/dL 4.0 (3.8-4.3)
eGFR, ml/min/1.73m2 78.0 (67.0-90.0)
Hb, g/dL 14.2 (13.1-15.0)
HbA1c, % 5.8 (5.6-6.4)
TG, mg/dL 81 (51-139)
LDL-C, mg/dL 120 (94-145)
HDL-C, mg/dL 50 (42-61)
CRP, mg/dL 0.08 (0.04-0.28)
Hemodynamic findings
Blood Pressure, mmHg
Systolic 137 (122-154)
Diastolic 79 (69-88)
Mean 105 (93-114)
LVEDP, mmHg 15 (11-20)
LVEDV, mL 105.5 (87.5-125.1)
LVEDVI, mL/m2 59.8 (50.2-69.7)
LVESV, mL 45.3 (35.1-57.1)
LVESVI, mL/m2 25.2 (20.2-31.8)
LVEF, % 56.7 (49.8-63.0)
Diagnosis
Myocardial infarction (%) 277 (49.7%)
Unstable angina (%) 280 (50.3%)
Rhythm
Sinus rhythm 537 (96.4%)
Atrial fibrillation 12 (2.2%)
Others 8 (1.4%)
Medications
ACE inhibitors (%) 19 (3.4%)
ARBs (%) 159 (28.5%)
ARNIs (%) 2 (0.4%)
Beta blockers (%) 83 (14.9%)
Calcium channel blockers (%) 191 (34.3%)
Diuretics (%) 34 (6.1%)

Abbreviations: ACE = angiotensin converting enzyme; ARB = angiotensin II type I-receptor blockers; ARNI = angiotensin receptor neprilysin inhibitor; BMI = body mass index; BNP = B-type natriuretic peptide; CRP = C-reactive protein; eGFR = estimated glomerular filtration rate; Hb = hemoglobin; HbA1c = hemoglobin A1c; HDL-C = high-density lipoprotein; IQR = interquartile range; LDL-C = low-density lipoprotein; LVEDP = left ventricular end-diastolic pressure; LVEDV = left ventricular end-diastolic volume; LVEDVI = left ventricular end-diastolic volume index; LVEF = left ventricular ejection fraction; LVESV = left ventricular end-systolic volume; LVESVI = left ventricular end-systolic volume index; TG = triglycerides.